MedTrace Logo

Dual Trigger Versus Booster Dose of HCG

NCT02397642 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2018-01-29

No results posted yet for this study

Summary

To salvage the luteal phase and improve pregnancy rate in antagonist IVF/ICSI cycles triggered with GnRH agonist. Two strategies are compared dual trigger with GnRH agonist plus 1000 IU of HCG or triggering with GnRH and giving a booster dose of HCG (1500 IU) on the day of ovum pickup.

Conditions

Interventions

PROCEDURE

IVF/ICSI

DRUG

Human Chorionic Gonadotropin

given in different doses and timing to support the luteal phase

Sponsors & Collaborators

  • Nile Ivf Center, Cairo, Egypt

    collaborator OTHER

  • Adam International Hospital

    collaborator OTHER

  • Cairo University

    lead OTHER

Principal Investigators

  • Sarwat Ahwany, MD · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
37 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2018-01-31
Completion
2018-01-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02397642 on ClinicalTrials.gov